NCT05268380View on ClinicalTrials.gov

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia

CompletedOBSERVATIONAL
Enrollment

1,750

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

February 29, 2024

Conditions
COVID-19HIV SeropositivityTuberculosis, PulmonaryTuberculosis Infection
Interventions
DIAGNOSTIC_TEST

Covid-19, TB and HIV diagnosis

GeneXpert (sputum) will be used to diagnose active TB disease, IGRA will be used to diagnose latent TB infection, PCR will be used to diagnose Covid-19 active infection, HIV rapid test will be used to diagnose HIV seropositivity.

Trial Locations (1)

Unknown

University of Namibia, Windhoek

All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

collaborator

Research Center Borstel

OTHER

collaborator

Victus Global Botswana Organization

UNKNOWN

lead

University of Namibia

OTHER